
With well-publicized losses for companies including UnitedHealth Group (NYSE: UNH), Elevance Health (NYSE: ELV), and Wegovy and Ozempic maker Novo Nordisk (NYSE: NVO), the healthcare sector failed to outperform the broad market last year.
In the three years prior to that, the sector finished with gains of just 2.6% in 2024 and 2.1% in 2023, and a loss of 2.0% in 2022.